Lv1
50 积分 2023-08-23 加入
Single-cell screens identify ADAM12 as a fibroblast checkpoint impeding anti-tumor immunity
1个月前
已完结
Efficacy and Safety of Immunotherapy Combined with Anlotinib as First-Line Treatment in Older NSCLC Patients with PD-L1 Expression<50%
1个月前
已完结
Minimally invasive hilum-mediastinal lymph nodes dissection for non-small cell lung cancer surgery: What is the future direction?
2个月前
已完结
Determinants of successful minimally invasive surgery for resectable non–small cell lung cancer after neoadjuvant therapy
2个月前
已完结
Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC)
2个月前
已完结
Determinants of successful minimally invasive surgery (MIS) for resectable non-small cell lung cancer (NSCLC) after neoadjuvant therapy
2个月前
已完结
Minimally Invasive Resection of Non-small Cell Lung Cancer after Chemoimmunotherapy – A Multicenter Study in Academic Hospitals
2个月前
已完结
Lung cancer
2个月前
已完结
Perioperative Strategies in Non-Small Cell Lung Cancer: Immunotherapy and Targeted Therapy
2个月前
已完结
Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study
3个月前
已完结
皖公网安备34019202002308
